By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1 North Waukegan Road

North Chicago  Illinois  60064  U.S.A.
Phone: 1-800-255-5162 Fax: n/a


AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

Key Statistics

Ownership: Public

Web Site: AbbVie
Symbol: ABBV


Company News
AbbVie (ABBV) Announces High Sustained Virologic Response Rates In Phase 2 Studies With Pan-Genotypic, Investigational Regimen In Patients With Chronic Hepatitis C 11/16/2015 7:39:48 AM
AbbVie (ABBV)'s VIEKIRA PAK Shows 95% Cure Rate in as Little as 12 Weeks in Phase III Hepatitis C Study 11/16/2015 6:02:36 AM
AbbVie (ABBV) Submits IMBRUVICA (ibrutinib) Phase III Combination Data To U.S. FDA 11/13/2015 7:06:25 AM
AbbVie (ABBV) To Present At Jefferies Autumn 2015 Global Healthcare Conference In London 11/5/2015 11:07:40 AM
AbbVie (ABBV)'s Commitment To Oncology Demonstrated At The 57th American Society of Hematology Annual Meeting With 61 Abstracts Evaluating Medicines In Several Blood Cancers 11/5/2015 10:55:02 AM
AbbVie (ABBV)'s Leadership And Innovation In Immunology Showcased At The American College of Rheumatology Annual Meeting With More Than 40 Abstracts On HUMIRA (adalimumab) And Investigational Medicines Across Multiple Inflammatory Diseases 11/3/2015 7:40:14 AM
AbbVie (ABBV) To Present At Credit Suisse 24th Annual Healthcare Conference 11/2/2015 10:40:28 AM
Shares Pop as AbbVie (ABBV) Beats Expectations and Projects Double Digit Growth to 2020 10/30/2015 5:59:03 AM
AbbVie (ABBV) Release: IMBRUVICA (ibrutinib) Awarded Prix Galien 2015 Best Pharmaceutical Agent 10/28/2015 11:44:34 AM
AbbVie (ABBV)'s Pain is Gilead (GILD)'s Gain After FDA Slaps Warning on AbbVie’s Hepatitis Drugs 10/23/2015 5:58:29 AM